Slide 1: Analyst Conference Call Q1 2024
Analyst Conference Call Q1 2024 NovaFlex SharkSkin April 25, 2024 by BASF 1 April 25, 2024 | BASF Analyst Conference Call Q1 2024
Slide 2: Cautionary note regarding forward-looking statements
Cautionary note regarding forward-looking statements This presentation contains forward-looking statements. These statements are based on current estimates and projections of the Board of Executive Directors and currently available information. Forward-looking statements are not guarantees of the fu
Slide 3: Global chemical production grew compared with Q1 2023, driven by strong growth in China
Global chemical production grew compared with Q1 2023, driven by strong growth in China; production in Europe increased slightly Chemical production compared with prior-year quarter1 % North America EU Mainland China Asia excl. mainland China 0.5 9.6 0.1 7.2 -2.0 -2.8 -14.9 -9.7 Q1 2023 Q1 2024 Q1 2
Slide 4: BASF with solid start to the year: Q1 2024 slightly ahead of analyst consensus
BASF with solid start to the year: Q1 2024 EBITDA before special items slightly ahead of analyst consensus Sales development Volumes Prices Portfolio Currency In Q1 2024, sales declined by 12% to €17.6 billion, Q1 2024 vs. Q1 2023 mainly due to lower prices and negative currency effects 0.5% -10.4
Slide 5: BASF achieved volume growth in the Chemicals, Materials, Nutrition & Care and Industrial Solutions segments
BASF achieved volume growth in the Chemicals, Materials, Nutrition & Care and Industrial Solutions segments Volume development by segment Q1 2024 vs. Q1 2023 Absolute change, million € Industrial Surface Solutions Technologies 125 -288 Agricultural Nutrition Materials & Care Solutions 218 151 -364 C
Slide 6: BASF Group Q1 2024: Key financial figures
BASF Group Q1 2024: Key financial figures EBITDA before special items EBIT before special items Net income Q1 2024 vs. Q1 2023 Q1 2024 vs. Q1 2023 Q1 2024 vs. Q1 2023 €2,712 million €1,754 million €1,368 million -5.3% -9.2% -12.4% Operating cash flow Free cash flow Equity ratio Q1 2024 vs. Q1 2023 Q
Slide 7: EBITDA before special items increased in the Nutrition & Care, Materials, Industrial Solutions and Chemicals segments
EBITDA before special items increased in the Nutrition & Care, Materials, Industrial Solutions and Chemicals segments BASF Industrial Surface Nutrition Agricultural BASF Group Chemicals Materials Solutions Technologies & Care Solutions Other Group EBITDA before special items Q1 2024 vs. Q1 2023 Mill
Slide 8: Cash flow generation in Q1 2024 improved strongly compared with prior-year quarter
Cash flow generation in Q1 2024 improved strongly compared with prior-year quarter due to less cash tied up in net working capital Q1 2024 Q1 2023 Q1 2024 vs. Q1 2023 Million € Million € Cash flows from operating activities improved by €502 million to -€513 million Changes in net working capital
Slide 9: Strong balance sheet
Strong balance sheet Balance sheet March 31, 2024, vs. December 31, 2023 Billion € Total assets increased by €4.3 billion to €81.7 billion, mainly due to higher current 81.7 81.7 assets; the seasonality of the Agricultural 77.4 77.4 Solutions business led to particularly higher trade accounts rece
Slide 10: Outlook 2024 for BASF Group unchanged
Outlook 2024 for BASF Group unchanged Outlook 2024 EBITDA before special items €8.0 billion – €8.6 billion Free cash flow €0.1 billion – €0.6 billion CO2 emissions 16.7 million – 17.7 million metric tons Underlying assumptions Growth in gross domestic product: 2.3% Growth in industrial productio
Slide 11: BASF - We create chemistry
O- BASF We create chemistry